What Researchers Did
This review distinguished between pharmacotherapies for age-related behavioral deficiencies and those for general psychiatric disorders, examining responses to drugs specifically for older adults.
What They Found
The review found that placebo-controlled studies confirmed numerous positive responses to drugs specifically designed for treating impaired behavior in older individuals. Furthermore, responses in normal or mildly impaired subjects suggested potential prophylactic applications for some of these medications.
What This Means for Canadian Patients
This early review highlights the potential for specific pharmacotherapies to address age-related behavioral deficiencies in older Canadian patients. It suggests that targeted drug interventions could improve quality of life and potentially prevent further decline in some individuals.
Canadian Relevance
This study has no direct Canadian connection.
Study Limitations
As an early review from 1981, this study's findings may be limited by the available research at that time and the lack of specific quantitative data.